3- year efficacy and safety for liraglitude 3.0mg in adults with obesity/overweight, prediabetes and baseline BMI <35 vs >/=35kg/m2 in the SCALE obesity and and pore diabetes, double-blind, placebo-controlled trial

Fasanmade, O ; Greenway, F ; Le Roux, C.W ; McGowan, B ; Pi-Sunyer, X ; Cancino, A.P (2007-09)

Presentation